A review of imiquimod 5% cream for the treatment of various dermatological conditions.
Salasche
S
S
Clinical Professor of Medicine, Department of Medicine, Section of Dermatology, University of Arizona Health Sciences Center, Arizona, USA.
Shumack
S
S
D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000287:Administration, Topical; D000634:Aminoquinolines / Q000008:administration & dosage*; D003218:Condylomata Acuminata / Q000188:drug therapy; D004643:Emollients / Q000008:administration & dosage; D005260:Female; D006801:Humans; D000077271:Imiquimod; D008297:Male; D008562:Membrane Glycoproteins / Q000187:drug effects; D009824:Ointments; D011956:Receptors, Cell Surface / Q000187:drug effects; D012871:Skin Diseases / Q000188:drug therapy*; D051193:Toll-Like Receptors
D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D004643:Emollients; D008562:Membrane Glycoproteins; D009824:Ointments; D011956:Receptors, Cell Surface; D051193:Toll-Like Receptors; D000077271:Imiquimod